Want to create an interactive transcript for this episode?
Podcast: BioTech Nation ... with Dr. Moira Gunn
Episode: A Different Approach, A New Cancer Drug... Dr. Paul Lammers, CEO Triumvira Immunologics
Description: Cancer treatments which work with the immune system are making great strides, with Keytruda from Merck being perhaps the best known. Still there is much work to be done – both in developing unprecedented new treatments, as well as treatments which might combine with our existing treatments to make them even more effective. Triumvera (try-um-VEERA) Immunologics is working on both. Dr. Paul Lammers is its CEO.Â